+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Global Varicose Vein Treatment Devices Market (2021-2026) by Treatment Type, Product, Geography, Competitive Analysis and the Impact of Covid-19 with Ansoff Analysis

  • PDF Icon


  • 170 Pages
  • April 2021
  • Region: Global
  • Infogence Global Research
  • ID: 5392886
The Global Varicose Vein Treatment Devices Market is estimated to be USD 1.2 Bn in 2021 and is expected to reach USD 2.04 Bn by 2026, growing at a CAGR of 11.2%.

Market Dynamics

According to the study published in BMC Nursing 2020, around 20 to 60% of adults are affected by common chronic venous disorders globally. The varicose vein is a genetic disease, thus increasing the risk of the development of the disease. The increasing prevalence of obesity, heart diseases, and rising alcoholic consumption has further increased the risk of varicose veins disease. Growing awareness for minimally invasive procedures, increasing geriatric population, increasing healthcare expenditure have fueled the market growth. Major company players are investing in developing technologically advanced varicose vein treatment devices that are anticipated to offer remunerative growth opportunities for the player operating in the market.

However, the high cost and risk associated with the varicose vein treatment are anticipated to hinder the market growth.

Market Segmentation

The Global Varicose Vein Treatment Devices Market is segmented further based on Treatment Type, Product, and Geography.

By Treatment Type, the market is classified into Injection Sclerotherapy, Endovenous Ablation, and Surgical Ligation/Stripping. Amongst all, the Injection Sclerotherapy segment is estimated to hold the highest market share during the forecast period.

By Product, the market is classified as ablation devices, venous closure products, and surgical products. Amongst all, the ablation devices segment is estimated to hold the highest market share during the forecast period.

By Geography, North America is projected to lead the market.

Recent Developments

1. THERACLION, an innovative company specialized in echotherapy treatment, obtained CE Mark for the second generation of SONOVEIN®, its HIFU treatment solution for varicose veins. - 15th October 2020.
1. Mumbai-based The Vein Center has partnered with Apollo Clinic for providing OPD and ultrasound examination services to patients of Apollo Clinic. The tie-up will provide patients access to the right solutions from the experts for dealing with the growing lifestyle disease of varicose veins. - 5th February 2020.
2. Biolitec AG launched Biolitec Phlebology App on Varicose Veins for vascular surgeons, phlebologists, and dermatologists for the exchange of experiences on therapies with colleagues in the Physicians Forum. - 3rd February 2020.

Company Profiles

Some of the companies covered in this report Won Tech Co., Ltd, Dornier MedTech GmbH, Syneron Medical Ltd., Medtronic Plc, Lumenis Corporation, Quanta System, Teleflex Incorporated, Energist Ltd, etc.

Competitive Quadrant

The report includes a Competitive Quadrant, a proprietary tool to analyze and evaluate the position of companies based on their Industry Position score and Market Performance score. The tool uses various factors for categorizing the players into four categories. Some of these factors considered for analysis are financial performance over the last 3 years, growth strategies, innovation score, new product launches, investments, growth in market share, etc.

Why buy this report?
  • The report offers a comprehensive evaluation of the Global Varicose Vein Treatment Devices Market. The report includes in-depth qualitative analysis, verifiable data from authentic sources, and projections about market size. The projections are calculated using proven research methodologies.
  • The report has been compiled through extensive primary and secondary research. The primary research is done through interviews, surveys, and observation of renowned personnel in the industry.
  • The report includes an in-depth market analysis using Porter’s 5 forces model and the Ansoff Matrix. In addition, the impact of Covid-19 on the market is also featured in the report.
  • The report also includes the regulatory scenario in the industry, which will help you make a well-informed decision. The report discusses major regulatory bodies and major rules and regulations imposed on this sector across various geographies.
  • The report also contains a competitive analysis using the Positioning Quadrants, the analyst’s Proprietary competitive positioning tool.

Report Highlights:
  • A complete analysis of the market, including parent industry
  • Important market dynamics and trends
  • Market segmentation
  • Historical, current, and projected size of the market based on value and volume
  • Market shares and strategies of key players
  • Recommendations to companies for strengthening their foothold in the market
Frequently Asked Questions about the Global Varicose Vein Treatment Devices Market

What is the estimated value of the Global Varicose Vein Treatment Devices Market?

The Global Varicose Vein Treatment Devices Market was estimated to be valued at $1200 Million in 2021.

What is the growth rate of the Global Varicose Vein Treatment Devices Market?

The growth rate of the Global Varicose Vein Treatment Devices Market is 11.2%, with an estimated value of $2040 Million by 2026.

What is the forecasted size of the Global Varicose Vein Treatment Devices Market?

The Global Varicose Vein Treatment Devices Market is estimated to be worth $2040 Million by 2026.

Who are the key companies in the Global Varicose Vein Treatment Devices Market?

Key companies in the Global Varicose Vein Treatment Devices Market include Alma Lasers Ltd, Alna group, AngioDynamics, Inc., Biolitec AG, BTG International Ltd, Dornier MedTech GmbH, Energist Ltd., Eufoton s.r.l. and INTERmedic.

Table of Contents

1 Report Description
1.1 Study Objectives
1.2 Market Definition
1.3 Currency
1.4 Years Considered
1.5 Language
1.6 Key Shareholders
2 Research Methodology
2.1 Research Process
2.2 Data Collection and Validation
2.2.1 Secondary Research
2.2.2 Primary Research
2.2.3 Models
2.3 Market Size Estimation
2.3.1 Bottom-Up Approach
2.3.2 Top-Down Approach
2.4 Assumptions of the Study
2.5 Limitations of the Study
3 Executive Summary
3.1 Introduction
3.2 Market Size and Segmentation
3.3 Market Outlook
4 Market Influencers
4.1 Drivers
4.1.1 Increasing Prevalence of Varicose Diseases
4.1.2 Adoption of Endovenous Laser Ablation
4.1.3 Rising Geriatric Population and Healthcare Expenditure
4.2 Restraints
4.2.1 Stringent Government Regulation for Medical Devices
4.2.2 Risk Associated with the Surgeries
4.3 Opportunities
4.3.1 Increasing Awareness of Minimally Invasive Techniques
4.3.2 Technological Advancements in the Devices
4.4 Challenges
4.4.1 Lack Of Skilled Professional and High-Cost Procedures
4.5 Trends
5 Market Analysis
5.1 Regulatory Scenario
5.2 Porter’s Five Forces Analysis
5.3 Impact of COVID-19
5.4 Ansoff Matrix Analysis
6 Global Varicose Vein Treatment Devices Market, By Treatment Type
6.1 Introduction
6.2 Injection Sclerotherapy
6.3 Endovenous Ablation
6.4 Surgical Ligation/Stripping
7 Global Varicose Vein Treatment Devices Market, By Product
7.1 Introduction
7.2 Ablation Devices
7.2.1 Radiofrequency Ablation Devices
7.2.2 Laser Ablation Devices
7.3 Venous Closure Products
7.4 Surgical Products
8 Global Varicose Vein Treatment Devices Market, By Geography
8.1 Introduction
8.2 North America
8.2.1 US
8.2.2 Canada
8.2.3 Mexico
8.3 South America
8.3.1 Brazil
8.3.2 Argentina
8.3.3 Chile
8.3.4 Colombia
8.4 Europe
8.4.1 UK
8.4.2 France
8.4.3 Germany
8.4.4 Italy
8.4.5 Spain
8.4.6 Netherlands
8.4.7 Sweden
8.4.8 Russia
8.4.9 Rest of Europe
8.5 Asia-Pacific
8.5.1 China
8.5.2 Japan
8.5.3 India
8.5.4 Indonesia
8.5.5 Malaysia
8.5.6 South Korea
8.5.7 Australia
8.5.8 Sri Lanka
8.5.9 Thailand
8.5.10 Rest of APAC
8.6 Middle-East and Africa
8.6.1 Qatar
8.6.2 Saudi Arabia
8.6.3 South Africa
8.6.4 United Arab Emirates
9 Competitive Landscape
9.1 Competitive Quadrant
9.2 Market Share Analysis
9.3 Strategic Initiatives
9.3.1 M&A and Investments
9.3.2 Partnerships and Collaborations
9.3.3 Product Developments and Improvements
10 Company Profiles
10.1 Alma Lasers Ltd
10.2 Alna group
10.3 AngioDynamics, Inc.
10.4 Biolitec AG
10.5 BTG International Ltd
10.6 Dornier MedTech GmbH
10.7 Energist Ltd.
10.8 Eufoton s.r.l.
10.10 INTERmedic
10.11 LSO Medical
10.12 Lumenis Corporation
10.13 Medtronic Plc
10.14 Quanta System
10.15 Sciton, Inc.
10.16 Syneron Medical Ltd.
10.17 Teleflex Incorporated
10.18 Vascular Solutions, Inc.
10.19 Vydence Medical
10.20 Won Tech Co., Ltd
11 Appendix
11.1 Questionnaire

Companies Mentioned

  • Alma Lasers Ltd
  • Alna group
  • AngioDynamics, Inc.
  • Biolitec AG
  • BTG International Ltd
  • Dornier MedTech GmbH
  • Energist Ltd.
  • Eufoton s.r.l.
  • INTERmedic
  • LSO Medical
  • Lumenis Corporation
  • Medtronic Plc
  • Quanta System
  • Sciton, Inc.
  • Syneron Medical Ltd.
  • Teleflex Incorporated
  • Vascular Solutions, Inc.
  • Vydence Medical
  • Won Tech Co., Ltd